United Therapeutics | UTHR - Pre Tax Profit


United Therapeutics reported $444M in Pre-Tax Profit for its fiscal quarter ending in December of 2025.





Pre Tax Profit Change Date
Amarin USD -852K 7.26M Dec/2025
Ardelyx USD -400K 467K Dec/2025
Baxter International USD -756M 877M Dec/2025
Bayer EUR -3.37B 2.21B Dec/2025
BioCryst Pharmaceuticals USD 248.02M 235.89M Dec/2025
Biogen USD 377.7M 433.7M Mar/2026
BioMarin Pharmaceutical USD 141.2M 168.36M Mar/2026
Esperion Therapeutics USD 63.67M 95M Dec/2025
Gilead Sciences USD 2.08B 1.56B Dec/2025
GlaxoSmithKline GBP 2.14B 919M Mar/2026
Halozyme Therapeutics USD 180.33M 281.18M Mar/2026
Insmed USD -162.1M 164.84M Mar/2026
Ionis Pharmaceuticals USD -93M 135M Mar/2026
J&J USD 7.82B 2.86B Mar/2026
Lexicon Pharmaceuticals USD -12.77M 16.02M Sep/2025
Moderna USD -799M 612M Dec/2025
Omeros USD -65.12M 21.27M Jun/2024
Pfizer USD 5.18B 6.82B Mar/2026
PTC Therapeutics USD -2.46M 136.62M Mar/2026
Regeneron Pharmaceuticals USD 1.04B 719.6M Dec/2025
Sangamo BioSciences USD -36.05M 12.94M Jun/2024
Sarepta Therapeutics USD 343.17M 750.85M Mar/2026
Teva Pharmaceutical Industries USD 753M 662M Mar/2026
United Therapeutics USD 444M 6M Dec/2025
Vertex Pharmaceuticals USD 1.25B 78.1M Mar/2026